
CLI Ventures
Description
CLI Ventures is a Palo Alto, California-based venture capital firm specializing in early-stage investments across the global technology and healthcare sectors. Established in 2022, the firm targets companies from Seed to Series A rounds that are developing disruptive technologies and innovative solutions. Their investment thesis centers on high-growth areas including Artificial Intelligence (AI), Biotechnology, Digital Health, Enterprise SaaS, and Fintech, reflecting a broad yet focused approach to emerging markets.
The firm's investment strategy is characterized by its commitment to providing not just capital but also comprehensive support to its portfolio companies. CLI Ventures typically deploys initial checks ranging from $500,000 to $3,000,000, with additional capital reserved for follow-on rounds to support continued growth. This range positions them as a significant early-stage investor capable of fueling initial product development and market entry for promising startups. Beyond financial backing, CLI Ventures emphasizes strategic guidance, operational support, and access to their extensive network, aiming to accelerate the global scaling of their portfolio companies.
Despite being a relatively new entrant in the venture capital landscape, having been founded in 2022, CLI Ventures has quickly established a clear investment mandate. Their focus on global expansion for portfolio companies, even from their Silicon Valley base, highlights a forward-thinking approach to market opportunities. By concentrating on critical sectors like AI and biotech, they align with major innovation trends. The firm's hands-on approach and commitment to post-investment support are designed to foster long-term success and help founders navigate the complexities of scaling a technology or healthcare venture.
Investor Profile
CLI Ventures has backed more than 22 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Convertible Note, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Software, Biotechnology, Health Care.
- Typical check size: $500K – $3M.
Stage Focus
- Seed (45%)
- Convertible Note (14%)
- Series A (14%)
- Series C (9%)
- Series B (9%)
- Series Unknown (5%)
- Pre Seed (5%)
Country Focus
- United States (100%)
Industry Focus
- Software
- Biotechnology
- Health Care
- Robotics
- Big Data
- Artificial Intelligence (Ai)
- E-commerce
- Logistics
- Mobile
- Saas
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.